Living with heart failure

Living with heart failure

Heart failure treatments have been proven successful in reducing mortality, preventing repeated hospitalizations, and improving patients’ quality of life. But this effectiveness can only be achieved if the treatments are taken regularly and appropriately. Unfortunately, however, patient adherence remains low, with only one in two heart failure patients fully complying with their prescribed plan4. One of the main barriers to adherence is the complexity of treatment regimens. That is, between 25% and 50% of heart failure patients are prescribed 10 or more pills per day5, making compliance challenging and increasing the risk of missed doses or treatment discontinuation.

From a medical standpoint, patients are considered “non-adherent” if they follow less than 80 % of their prescribed treatment6.

Throughout the month of June, Servier and its partners around the world are focusing their efforts on the “Every Pill Matters” awareness campaign, a program designed with and for patients with heart failure. The goal is to ensure that every treatment prescribed is taken as directed.

The campaign is structured around three key components:

  • Educating: Sharing informative content and real-life stories from patients, caregivers, and healthcare professionals to help people understand the importance of treatment adherence.
  • Empowering: Encouraging patients to take control of their healthcare journey by providing them with the tools for understanding and relevant information.
  • Enabling: Providing practical advice and showcasing innovative solutions such as the MyHealthPartner website.

The “Every Pill Matters” campaign is being rolled out across social media – Instagram, Facebook, YouTube, LinkedIn, X, and Threads – to amplify the message. Targeting patients and healthcare professionals, various media are utilized, including videos, animated visuals, brochures, posters, and quizzes. The campaign offers a wealth of advice on how to better adhere to treatment on a daily basis and in a variety of situations, such as when traveling or in an emergency.

Learn more about Servier’s commitments in cardiometabolism

Read more


[1] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789–1858 https://www.thelancet.com/article/S0140-6736(18)32279-7/fulltext
[2] World Health Organization – Ageing and health – https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
[3] https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.120.007014
[4] https://pubmed.ncbi.nlm.nih.gov/37241192/
[5] Stolfo D et al. Eur J Heart Fail, 2025, https://openaccess.sgul.ac.uk/id/eprint/117411/1/European%20J%20of%20Heart%20Fail%20-%202025%20-%20Stolfo%20-%20How%20to%20handle%20polypharmacy%20in%20heart%20failure%20%20A%20clinical%20consensus%20statement%20of.pdf
[6] Médecine des Maladies Métaboliques, 2012,


link

Leave a Reply

Your email address will not be published. Required fields are marked *